ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 33 filers reported holding ANTHERA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $563,000 | -79.4% | 866,924 | 0.0% | 0.00% | – |
| Q3 2016 | $2,731,000 | +2.6% | 866,924 | +0.6% | 0.00% | – |
| Q2 2016 | $2,663,000 | -14.9% | 861,880 | -0.3% | 0.00% | -100.0% |
| Q1 2016 | $3,128,000 | -22.8% | 864,133 | -1.0% | 0.00% | 0.0% |
| Q4 2015 | $4,050,000 | -23.0% | 872,896 | +1.1% | 0.00% | 0.0% |
| Q3 2015 | $5,260,000 | -37.4% | 863,732 | -11.4% | 0.00% | 0.0% |
| Q2 2015 | $8,401,000 | +185.0% | 974,622 | +47.8% | 0.00% | – |
| Q1 2015 | $2,948,000 | +248.9% | 659,561 | +23.3% | 0.00% | – |
| Q4 2014 | $845,000 | -17.1% | 534,756 | +0.8% | 0.00% | – |
| Q3 2014 | $1,019,000 | -26.2% | 530,636 | +30.3% | 0.00% | – |
| Q2 2014 | $1,381,000 | +17.9% | 407,297 | +16.5% | 0.00% | – |
| Q1 2014 | $1,171,000 | +67.5% | 349,680 | +53.6% | 0.00% | – |
| Q4 2013 | $699,000 | +55.7% | 227,590 | +103.6% | 0.00% | – |
| Q3 2013 | $449,000 | – | 111,801 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,900,000 | $16,378,000 | 3.36% |
| Hilltop Park Associates LLC | 120,000 | $1,034,000 | 2.05% |
| Abingworth LLP | 437,994 | $3,767,000 | 1.71% |
| Sio Capital Management, LLC | 238,158 | $2,053,000 | 1.01% |
| Rhenman & Partners Asset Management AB | 619,600 | $5,341,000 | 0.64% |
| Broadfin Capital, LLC | 1,370,457 | $11,813,000 | 0.64% |
| Perceptive Advisors | 1,202,156 | $10,363,000 | 0.62% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 931,257 | $8,027,000 | 0.60% |
| WEXFORD CAPITAL LP | 177,500 | $1,530,000 | 0.41% |
| Rock Springs Capital Management LP | 470,000 | $4,051,000 | 0.30% |